StockNews.AI
TAK
StockNews.AI
201 days

Suffolk Celebrates Topping off for a Game-Changing New Takeda Facility in Kendall Square Where Science, Art and Community Will Converge

1. Takeda leases 600,000 sq. ft. for R&D in Kendall Square. 2. The new facility includes a performing arts center for community use. 3. Suffolk guarantees sustainability goals with LEED Gold certification plans. 4. Occupancy set for 2026, enhancing Cambridge's life sciences hub.

6m saved
Insight
Article

FAQ

Why Bullish?

The R&D center supports Takeda's growth strategy, similar to previous successful expansions.

How important is it?

The new facility aligns with Takeda's R&D goals, potentially accelerating market position.

Why Long Term?

The facility's completion will fortify Takeda's presence, affecting long-term performance.

Related Companies

TAKBMRSFG
BOSTON--(BUSINESS WIRE)--Suffolk, one of the largest and most innovative real estate and construction enterprises in the country, recently celebrated topping off 585 Kendall. Designed by CBT Architects, 585 Kendall is a mixed-use lab/office building and performing arts center in the Canal District of Kendall Square. The event recognized the construction teams that played a vital role in reaching this significant milestone. Takeda has leased the property’s approximately 600,000-square-foot of lab and office space, creating a purpose-built research and development facility to deliver life-transforming therapies for patients that will be the home of Takeda’s Global R&D center. Lexington will remain Takeda’s suburban campus. Maintaining the neighborhood’s reputation as a hub for science and the arts, the 16-story structure developed and owned by BioMed Realty is poised to establish a new cultural landmark for the community. Suffolk's approach to building the new facility is rooted in its commitment to quality and the latest advancements in construction technology, data and sustainable practices. Suffolk increases efficiencies and productivity on jobsites that allow its teams to build functional, sustainable buildings and research labs at the forefront of global biomedical innovation and deliver those buildings on schedule and on budget. "We are honored and privileged to celebrate this important milestone in the construction of this complex facility,” said John Fish, Chairman and CEO, Suffolk. “Building a sophisticated project in the heart of the innovation district of Cambridge requires vision, dedication, innovation and collaboration. Thank you to BioMed and Takeda for their close partnership, for their investment in this community, and for their faith in Suffolk to deliver this game-changing project for the life sciences community, the City of Cambridge and the Commonwealth of Massachusetts.” Set for occupancy in 2026, 585 Kendall is designed to support the diverse needs of the Cambridge community. The building’s 30,000-square-foot performing arts center with a 400-seat performance space, flexible multipurpose rooms for workshops and meetings, and an indoor garden developed in partnership with Global Arts Live will provide much-needed rehearsal, performance and gathering spaces for artists and community members. This performing arts center will complement the existing, ongoing community activations at Canal District Kendall. BioMed Realty and Takeda are also partnering to achieve key sustainability goals in the building’s development and operation, including LEED Gold or higher, as well as additional healthy building certifications. The building will be water and energy efficient and supplied with 100% renewable electricity to reduce greenhouse gas emissions. Enhanced ventilation strategies, avoiding chemicals of concern like volatile organic compounds (VOCs), and applying biophilic design principles, will improve occupant wellbeing, comfort, and productivity. About Suffolk Suffolk is a national enterprise that builds, innovates and invests. Suffolk is an end-to-end business that provides value throughout the entire project lifecycle by leveraging its core construction management services with vertical service lines that include real estate capital investment, design, self-perform construction services, technology start-up investment (Suffolk Technologies) and innovation research/development. Suffolk – America’s Contractor – is a national company with more than $5.5 billion in annual revenue, 2,800 employees, and offices in Boston, Massachusetts (headquarters); New York City, New York; Miami, West Palm Beach, Tampa and Estero in Florida; Dallas, Texas; Los Angeles, San Francisco and San Diego in California; Portland, Maine; and Herndon, Virginia. Suffolk manages some of the most complex, sophisticated projects in the country, serving clients in every major industry sector, including healthcare, life sciences, education, gaming, transportation/aviation, federal government and public work, mission critical, advanced technology and commercial. Suffolk is privately held and is led by founder, chairman and CEO John Fish. Suffolk is ranked #8 on ENR’s list of “Largest Domestic Builders” and #8 on its list of “Top CM-at-Risk Contractors.” For more information, visit www.suffolk.com and follow Suffolk on Facebook, Twitter, LinkedIn, YouTube, and Instagram.

Related News